kabutan

Japan Tissue Engineering Co., Ltd., July-September (2Q) Ordinary Profit Loss Narrows

Thu Oct 31, 2024 3:00 pm JST Earnings

7774 Japan Tissue Engineering Co., Ltd. 【J-GAAP】

Earnings Report

Japan Tissue Engineering Co., Ltd. <7774> [TSE-G] announced its financial results after the market closed on October 31st (15:00). The ordinary loss (non-consolidated) for the cumulative second quarter of the fiscal year ending March 2025 (April to September) expanded to a loss of 206 million yen (compared to a loss of 9 million yen in the same period last year).

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the ordinary profit for the October to March period (second half) is expected to surge by 2.1 times that of the same period last year, reaching 329 million yen.

In the most recent three-month period, from July to September (2Q), the ordinary loss improved to a deficit of loss of 14 million yen (compared to a loss of 23 million yen in the same period last year). The operating profit/loss margin improved from -4.1% in the same period last year to -1.9%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Sep, 2022 972 -420 -419 -421 -10.4 ー Oct 31, 2022 J-GAAP
Apr - Sep, 2023 1,246 -10 -9 -11 -0.3 ー Oct 31, 2023 J-GAAP
Apr - Sep, 2024 1,161 -207 -206 -225 -5.6 ー Oct 31, 2024 J-GAAP
YoY -6.8% -1,970.0% -2,188.9% -1,945.5% -1,813.8%

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2024 Guidance ー ー ー ー － 0 Apr 30, 2024 J-GAAP
Apr - Sep, 2024 Results 1,161 -207 -206 -225 -5.6 0 Oct 31, 2024 J-GAAP
Revision Rate － － － － －

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2023 1,268 154 156 154 3.8 0 Apr 30, 2024 J-GAAP
Oct - Mar, 2024 Guidance 1,783 327 329 312 7.7 0 Oct 31, 2024 J-GAAP
YoY +40.6% +112.3% +110.9% +102.6% +101.8%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2023 2,032 -728 -725 -729 -18.0 0 Apr 27, 2023 J-GAAP
Mar, 2024 2,514 144 147 143 3.5 0 Apr 30, 2024 J-GAAP
Mar, 2025 Guidance 2,944 120 123 87 2.1 0 Apr 30, 2024 J-GAAP
YoY +17.1% -16.7% -16.3% -39.2% -39.4%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jul - Sep, 2023 584 -24 -23 -24 -0.6 -4.1 Oct 31, 2023 J-GAAP
Oct - Dec, 2023 539 -41 -41 -42 -1.1 -7.6 Jan 30, 2024 J-GAAP
Jan - Mar, 2024 729 195 197 196 4.8 26.7 Apr 30, 2024 J-GAAP
Apr - Jun, 2024 442 -193 -192 -211 -5.2 -43.7 Jul 30, 2024 J-GAAP
Jul - Sep, 2024 719 -14 -14 -14 -0.4 -1.9 Oct 31, 2024 J-GAAP
YoY +23.1% +41.7% +39.1% +41.7% +44.4%

Related Articles